Centers for Disease Control and Prevention Guideline for Prescribing Opioids, 2022-Need for Integrating Dosing Benchmarks With Shared Decision-Making.

Sullivan, Mark D; Linder, Jeffrey A; Doctor, Jason N

Sullivan, Mark D; Linder, Jeffrey A; Doctor, Jason N.

Afiliación

Sullivan MD; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle.
Linder JA; Division of General Internal Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Doctor JN; Department of Health Policy and Management, Price School of Public Policy, University of Southern California, Los Angeles.

JAMA Intern Med ; 183(9): 899-900, 2023 09 01.

Article en En | MEDLINE | ID: mdl-37459113

This viewpoint evaluates the CDC's 2022 clinical practice guideline for prescribing opioids and suggests a model for supplemented shared decision-making between patients and clinicians about long-term opioid therapy.

Asunto(s)

Dolor Crónico; Trastornos Relacionados con Opioides; Estados Unidos; Humanos; Analgésicos Opioides/uso terapéutico; Benchmarking; Trastornos Relacionados con Opioides/prevención & control; Dolor Crónico/tratamiento farmacológico; Centers for Disease Control and Prevention, U.S.; Atención Primaria de Salud

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dolor Crónico / Trastornos Relacionados con Opioides Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: JAMA Intern Med Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google